The overexpression of NF-κB transcription factors is common in thyroid cancer, particularly in PDTC and ATC, and is associated with larger tumor size, nodal metastases, extrathyroidal extension, and BRAF p.V600E mutation [50,51,52]. This evidence concerns the gene BRAF and thyroid cancer.